HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $3.41 per share for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2019-11-08
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2019-03-31 was $2.83, a 2.41% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2018-03-31 was $2.90, a 4.92% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2017-03-31 was $3.05.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2016-03-31 was $0.00.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2018 was $2.84, a 6.89% decline from fiscal 2017.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2017 was $3.05, a 21.59% decline from fiscal 2016.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2016 was $3.89, a 30.04% decline from fiscal 2015.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2015 was $5.56, a 27.52% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2019-09-30 | $3.41 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | $3.48 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $2.83 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $2.84 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $2.82 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | $3.00 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | $2.90 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | $3.05 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $3.08 10-Q · filed 2017-11-02 | |||
| 2017-06-30 | $3.10 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | $3.05 10-Q · filed 2017-05-08 | |||
| 2016-12-31 | $3.89 10-K · filed 2018-03-16 | |||
| 2016-09-30 | $3.87 10-Q · filed 2016-11-03 | |||
| 2016-06-30 | $4.07 10-Q · filed 2016-08-04 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-16 | |||
| 2015-12-31 | $5.56 10-K · filed 2018-03-16 | |||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | |||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 | |||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 | |||
| 2014-12-31 | $4.36 10-K · filed 2017-03-17 | |||
| 2014-09-30 | $4.36 10-Q · filed 2014-11-06 | |||
| 2014-06-30 | $4.36 10-Q · filed 2014-08-07 | |||
| 2014-03-31 | $4.36 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | $4.07 10-K · filed 2016-04-29 | |||
| 2013-09-30 | $3.98 10-Q · filed 2013-11-08 | |||
| 2012-12-31 | $4.21 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |